WALCZAK

GROUP

Welcome to the Walczak Group

chemical tools and strategies to drive

new discoveries in the life sciences

CURRENT RESEARCH

MRSA.png

ABaumannii.png

We are developing tools that enable the synthesis and selective modifications of (oligo)saccharides with minimal synthetic effort and in high selectivities. These studies utilize catalytic processes compatible with a broad selection of functional groups and classes of substrates.

CURRENT RESEARCH

RECENT NEWS

01 / 19 / 2022

We are excited to welcome our new first year graduate students Charlie Lu, James Greenwood and Timothy Davis to the Walczak lab!

12 / 17 / 2021

A new pre-print just posted on ChemRxiv - congratulations to Watt and Garrett!

06 / 28 / 2021

We welcome three summer students: Bradley Johnson (University of Pittsburgh) and Peyton Tran (Bowdoin College).

New catalytic methods

We develop tools that enable the synthesis and selective modifications of (oligo)saccharides with minimal synthetic effort and in high selectivities. These studies utilize catalytic processes compatible with a broad selection of functional groups and classes of substrates.

Multidrug resistance

Bacterial multidrug resistance is a global health problem and we leverage our expertise in organic synthesis to address this important challenge. Our current interests are focused on thiopeptide antibiotics and related classes of natural products with validates activities. These studies are conducted in synergy with our efforts to develop synthetic vaccines against some of the most threatening pathogens.

WALCZAK

GROUP

Welcome to the Walczak Group

​

chemical tools and strategies to drive

new discoveries in the life sciences

CURRENT RESEARCH

We are developing tools that enable the synthesis and selective modifications of (oligo)saccharides with minimal synthetic effort and in high selectivities. These studies utilize catalytic processes compatible with a broad selection of functional groups and classes of substrates.

CURRENT RESEARCH

RECENT NEWS